The Latest in Pharmacy

FDA grants priority review to sNDA for dasatinib

July 12, 2017

Vaccine granted orphan designation for MDS

July 11, 2017

FDA approves new treatment for sickle cell disease

July 8, 2017

FDA puts pembrolizumab trials on clinical hold

July 6, 2017

EC approves therapy for relapsed/refractory BCP-ALL

July 4, 2017

FDA unveils plan to eliminate orphan designation backlog

July 1, 2017

EC grants factor IX therapy orphan designation

June 30, 2017

Lower dose of rivaroxaban receives priority review

June 29, 2017

Betrixaban receives FDA approval for VTE prophylaxis in adults

June 26, 2017

New SC rituximab formulation approved, reduces administration time

June 24, 2017

Fostamatinib under review by FDA for chronic ITP

June 21, 2017

Biosimilar rituximab approved in Europe

June 20, 2017

FDA approves daratumumab-POM-Dex combo for MM

June 19, 2017

Company pauses enrollment on 2 trials of pembrolizumab in MM

June 14, 2017

Recombinant coagulation factor IX approved for hemophilia B

June 7, 2017